As drug companies around the world rush to develop candidates for coronavirus vaccines, Pfizer announced encouraging early data from its own trials Monday. What do the preliminary results show, and even if they are borne out, what challenges remain with regard to production and distribution of the vaccine? Science correspondent Miles O’ Brien joins William Brangham to discuss.
Stream your PBS favorites with the PBS app: https://to.pbs.org/2Jb8twG
Find more from PBS NewsHour at https://www.pbs.org/newshour
Subscribe to our YouTube channel: https://bit.ly/2HfsCD6
Follow us:
Facebook: https://www.pbs.org/newshour
Twitter: https://www.twitter.com/newshour
Instagram: https://www.instagram.com/newshour
Subscribe:
PBS NewsHour podcasts: https://www.pbs.org/newshour/podcasts
Newsletters: https://www.pbs.org/newshour/subscribe
